Company / Income Tax
Zenas BioPharma, Inc. Income Tax History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax
-$79.0K
FY2025
5-year range
-$79.0K / $301.0K
FY2023-FY2025
Trend
-126.2%
vs FY2024
Sector context
#170 of 204
Health Care
What the data says
Zenas BioPharma, Inc.'s income tax of -$79,000 is lower than 83% of companies in the Health Care sector (FY2025). Improved from $301,000 to -$79,000 over the past 2 years.
Based on SEC 10-K filings.
-$79,000 in FY2025.
Improved from $301,000 to -$79,000 over the past 2 years.
Health Care sector context is included.
Income Tax over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 17% in Health CareTop 17% of 204This company -$79.0K Sector average $118.7M
▼
-100.1% below sector average
Key checks
Key Insights
- In FY2025, income tax decreased 126.2% year-over-year.
- Ranks #170 out of 204 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.51 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income TaxValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$79.0K | -126.2% |
| FY2024 | $301.0K | +0.0% |
| FY2023 | $301.0K | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026